Published in Healthcare Mergers, Acquisitions and Ventures Week, March 7th, 2009
Sucampo reported full year revenue of $112.1 million for 2008 as compared to $91.9 million for 2007, an increase of $20.2 million, or 22.0%.
Product royalty revenue from sales of Amitiza® (lubiprostone) in the U.S. increased by $6.9 million, or 25.1%, to $34.4 million for 2008 from $27.5 million for 2007...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.